Characterization of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne

Powder Diffraction

Volumn 23, Issue 2, 2008, Pages

  Castro, Gisele A ^a   Ferreira, Lucas A M ^a   Oréfice, Rodrigo L ^a   Buono, Vicente T L ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Encapsulation efficiency; Ion pairing; Retinoic acid; Solid lipid nanoparticles

Indexed keywords

ALL-TRANS RETINOIC ACIDS; CONTROLLED RELEASE; ENCAPSULATION EFFICIENCY; ION PAIRING; RETINOIC ACIDS; SOLID LIPID NANOPARTICLE (SLN); SOLID LIPID NANOPARTICLES; TOPICAL TREATMENTS;

DIFFERENTIAL SCANNING CALORIMETRY; DIFFRACTION; MATRIX ALGEBRA; NANOPARTICLES;

ENCAPSULATION;

EID: 44649132163     PISSN: 08857156     EISSN: 19457413     Source Type: Journal    
DOI: 10.1154/1.2903515     Document Type: Article

References (26)

1. Castro, G. A., Oŕfice, R. L., Vilela, J. M. C., Andrade, M. S., and Ferreira, L. A. M. (2007). " Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne.," J. Microencapsul. 24, 395-407.
2. Dingler, A. and Gohla, S. (2002). " Production of solid lipid nanoparticles (SLN): scaling up feasibilities.," J. Microencapsul. 19, 11-16.
3. Freitas, C. and Müller, R. H. (1999). " Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase.," Eur. J. Pharm. Biopharm. 47, 125-132.
4. Ellis, C. N., Millikan, L. E., Smith, E. B., Chalker, D. M., Swinyer, L. J., Katz, I. H., Berger, R. S., Mills, Jr., O. H., Baker, M., Verschoore, M., and Loesche, C. (1998). " Comparison of adapalene 01% solution and tretinoin 0025% gel in topical treatment of acne vulgaris.," Br. J. Dermatol. 139 (S52), 41-47.
5. Gollnick, H. and Schramm, M. (1998). " Topical drug treatment in acne.," Dermatology (Basel, Switz.) 196, 119-125.
6. Hu, L., Tang, X., and Cui, F. (2004). " Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.," J. Pharm. Pharmacol. 56, 1527-1535.
7. Jenning, V. (1999). " Feste Lipid-Nanopartikel (SLN) als Trägersystem für die dermale Applikation von Retinol: Wirkstoffinkorporation,-freisetzung und Struktur.," Ph.D thesis, Freie Universität Berlin, Berlin, Germany (in German).
8. Jenning, V. and Gohla, S. (2000). " Comparison of wax and glyceride solid lipid nanoparticles (SLN).," Int. J. Pharm. 196, 219-222.
9. Jenning, V. and Gohla, S. H. (2001). " Encapsulation of retinoids in solid lipid nanoparticles (SLN).," J. Microencapsul. 18, 149-158.
10. Jenning, V., Schäfer-Korting, M., and Gohla, S. (2000a). " Vitamin A-loaded solid lipid nanoparticles for topical use: Drug release properties.," J. Controlled Release 66, 115-126.
11. Jenning, V., Thünemann, A. F., and Gohla, S. (2000b). " Characterisation of a novel solid lipid nanoparticle carrier system based on binary mixtures of liquid and solid lipids.," Int. J. Pharm. 199, 167-177.
12. Kayali, I., Ward, A. J. I., Suhery, T., Friberg, S. E., Simion, A., and Rhein, L. D. (1991). " Interactions of retinoic acid with a model of stratum corneum lipids.," J. Dermal Clinical Evaluation Soc. 2, 7-17.
13. Larsson, K. (1966). " Classification of glyceride crystal forms.," Acta Chem. Scand. 20, 2255-2260.
14. Lim, S.-J. and Kim, C.-K. (2002). " Formulation parameters determining the physicochemical characteristics of solid lipid nanoparticles loaded with all-trans retinoic acid.," Int. J. Pharm. 243, 135-146.
15. Lim, S.-J., Lee, M.-K., and Kim, C.-K. (2004). " Altered chemical and biological activities of all-trans retinoic acid incorporated in solid lipid nanoparticle powders.," J. Controlled Release 100, 53-61.
16. Liu, J., Wen, H., Chen, H., Ni, Q., Xu, H., and Yang, X. (2007). " Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery.," Int. J. Pharm. 328, 191-195.
17. Manjunath, K. and Venkateswarlu, V. (2005). " Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration.," J. Controlled Release 107, 215-228.
18. Mills, Jr., O. H. and Berger, R. S. (1998). " Irritation potential of new topical tretinoin formulation and a commercially-available tretinoin formulation as measured by patch testing in human subjects.," J. Am. Acad. Dermatol. 38, S11-S16.
19. Müller, R. H., Mäder, K., and Gohla, S. (2000). " Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art.," Eur. J. Pharm. Biopharm. 50, 161-177.
20. Müller, R. H., Mehnert, W., Lucks, J.-S., Schwarz, C., zur Mühlen, A., Meyhers, H., Freitas, C., and Rühl, D. (1995). " Solid lipid nanoparticles (SLN)-an alternative colloidal carrier system for controlled drug delivery.," Eur. J. Pharm. Biopharm. 41, 62-69.
21. Münster, U., Nakamura, C., Haberland, A., Jores, K., Mehnert, W., Rummel, S., Schaller, M., Korting, H. C., Zouboulis, Ch. C., Blume-Peytavi, U., and Schäfer-Korting, M. (2005). " RU58841-myristate-prodrug development for topical treatment of acne and androgenetic alopecia.," Pharmazie 60, 8-12.
22. Precht, D. (1988). " Fat crystal structure in cream and butter.," in Crystallization and Polymorphism of Fats and Fatty Acids, edited by, N. Garti, and, K. Sato, (Marcel Dekker, New York), pp. 305-355.
23. United States Pharmacopoeial Convention (2003). The United States Pharmacopeia-National Formulary (USP 26-NF 21) (VSP, Rockville, Maryland), pp. 1861-1862.
24. Westesen, K., Bunjes, H., and Koch, M. H. J. (1997). " Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential.," J. Controlled Release 48, 223-236.
25. Webster, G. F. (1998). " Topical tretinoin in acne therapy.," J. Am. Acad. Dermatol. 39, S38-S44.
26. Yang, S. C., Lu, L. F., Cai, Y., Zhu, J. B., Liang, B. W., and Yan, C. Z. (1999). " Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain.," J. Controlled Release 59, 299-307.